Most in vivo 31P MR studies are realized on 3T MR systems that provide sufficient signal intensity for prominent phosphorus metabolites. The identification of these metabolites in the in vivo spectra is performed by comparing their chemical shifts with the chemical shifts measured in vitro on high-field NMR spectrometers. To approach in vivo conditions at 3T, a set of phantoms with defined metabolite solutions were measured in a 3T whole-body MR system at 7.0 and 7.5 pH, at 37 °C. A free induction decay (FID) sequence with and without 1H decoupling was used. Chemical shifts were obtained of phosphoenolpyruvate (PEP), phosphatidylcholine (PtdC), phosphocholine (PC), phosphoethanolamine (PE), glycerophosphocholine (GPC), glycerophosphoetanolamine (GPE), uridine diphosphoglucose (UDPG), glucose-6-phosphate (G6P), glucose-1-phosphate (G1P), 2,3-diphosphoglycerate (2,3-DPG), nicotinamide adenine dinucleotide (NADH and NAD+), phosphocreatine (PCr), adenosine triphosphate (ATP), adenosine diphosphate (ADP), and inorganic phosphate (Pi). The measured chemical shifts were used to construct a basis set of 31P MR spectra for the evaluation of 31P in vivo spectra of muscle and the liver using LCModel software (linear combination model). Prior knowledge was successfully employed in the analysis of previously acquired in vivo data.

Division of Endocrinology and Metabolism Department of Internal Medicine 3 Medical University of Vienna 1090 Vienna Austria

High Field MR Center Department of Biomedical Imaging and Image Guided Therapy Medical University of Vienna 1090 Vienna Austria

MR Unit Department of Diagnostic and Interventional Radiology Institute for Clinical and Experimental Medicine Videnska 1958 9 140 21 Prague Czech Republic

Zobrazit více v PubMed

Bottomley P.A., Hart H.R., Edelstein W.A., Schenck J.F., Smith L.S., Leue W.M., Mueller O.M., Redington R.W. Nmr Imaging Spectroscopy System to Study Both Anatomy and Metabolism. Lancet. 1983;2:273–274. doi: 10.1016/S0140-6736(83)90250-7. PubMed DOI

Šedivý P., Kipfelsberger M.C., Dezortová M., Krššák M., Drobný M., Chmelík M., Rydlo J., Trattnig S., Hájek M., Valkovič L. Dynamic 31P MR spectroscopy of plantar flexion: Influence of ergometer design, magnetic field strength (3 and 7 T), and RF-coil design. Med. Phys. 2015;42:1678–1689. doi: 10.1118/1.4914448. PubMed DOI

Valkovič L., Chmelík M., Krššák M. In-vivo (31)P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. Anal. Biochem. 2017;529:193–215. doi: 10.1016/j.ab.2017.01.018. PubMed DOI PMC

Chmelík M., Valkovič L., Wolf P., Bogner W., Gajdošík M., Halilbasic E., Gruber S., Trauner M., Krebs M., Trattnig S., et al. Phosphatidylcholine contributes to in vivo (31)P MRS signal from the human liver. Eur. Radiol. 2015;25:2059–2066. doi: 10.1007/s00330-014-3578-y. PubMed DOI

Bierwagen A., Begovatz P., Nowotny P., Markgraf D., Nowotny B., Koliaki C., Giani G., Klüppelholz B., Lundbom J., Roden M. Characterization of the peak at 2.06 ppm in (31) P magnetic resonance spectroscopy of human liver: Phosphoenolpyruvate or phosphatidylcholine? NMR Biomed. 2015;28:898–905. doi: 10.1002/nbm.3323. PubMed DOI

Sevastianova K., Hakkarainen A., Kotronen A., Cornér A., Arkkila P., Arola J., Westerbacka J., Bergholm R., Lundbom J., Lundbom N., et al. Nonalcoholic fatty liver disease: Detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. Radiology. 2010;256:466–473. doi: 10.1148/radiol.10091351. PubMed DOI

Szendroedi J., Schmid A.I., Chmelik M., Krssak M., Nowotny P., Prikoszovich T., Kautzky-Willer A., Wolzt M., Waldhäusl W., Roden M. Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control. PLoS ONE. 2011;6:e21846. doi: 10.1371/journal.pone.0021846. PubMed DOI PMC

Sedivy P., Dezortova M., Drobny M., Dubsky M., Dusilova T., Kovar J., Hajek M. Origin of the (31) P MR signal at 5.3 ppm in patients with critical limb ischemia. NMR Biomed. 2020;33:e4295. doi: 10.1002/nbm.4295. PubMed DOI

Dezortova M., Taimr P., Skoch A., Spicak J., Hajek M. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J. Gastroenterol. 2005;11:6926–6931. doi: 10.3748/wjg.v11.i44.6926. PubMed DOI PMC

Beiglbock H., Wolf P., Pfleger L., Caliskan B., Fellinger P., Zettinig G., Anderwald C.H., Kenner L., Trattnig S., Kautzky-Willer A., et al. Effects of Thyroid Function on Phosphodiester Concentrations in Skeletal Muscle and Liver: An In Vivo NMRS Study. J. Clin. Endocrinol. Metab. 2020;105:e4866–e4874. doi: 10.1210/clinem/dgaa663. PubMed DOI

Valkovič L., Chmelík M., Ukropcová B., Heckmann T., Bogner W., Frollo I., Tschan H., Krebs M., Bachl N., Ukropec J., et al. Skeletal muscle alkaline Pi pool is decreased in overweight-to-obese sedentary subjects and relates to mitochondrial capacity and phosphodiester content. Sci. Rep. 2016;6:20087. doi: 10.1038/srep20087. PubMed DOI PMC

Kan H.E., Klomp D.W.J., Wong C.S., Boer V.O., Webb A.G., Luijten P.R., Jeneson J.A. In vivo 31P MRS detection of an alkaline inorganic phosphate pool with short T1 in human resting skeletal muscle. NMR Biomed. 2010;23:995–1000. doi: 10.1002/nbm.1517. PubMed DOI PMC

Van Oorschot J.W.M., Schmitz J.P.J., Webb A., Nicolay K., Jeneson J.A.L., Kan H.E. 31P MR Spectroscopy and Computational Modeling Identify a Direct Relation between Pi Content of an Alkaline Compartment in Resting Muscle and Phosphocreatine Resynthesis Kinetics in Active Muscle in Humans. PLoS ONE. 2013;8:e76628. doi: 10.1371/journal.pone.0076628. PubMed DOI PMC

Provencher S.W. Estimation of Metabolite Concentrations from Localized in-Vivo Proton Nmr-Spectra. Magn. Reson. Med. 1993;30:672–679. doi: 10.1002/mrm.1910300604. PubMed DOI

Deelchand D.K., Nguyen T.M., Zhu X.H., Mochel F., Henry P.G. Quantification of in vivo (3)(1)P NMR brain spectra using LCModel. NMR Biomed. 2015;28:633–641. doi: 10.1002/nbm.3291. PubMed DOI PMC

Li S., van der Veen J.W., An L., Stolinski J., Johnson C., Ferraris-Araneta M., Victorino M., Tomar J.S., Shen J. Cerebral phosphoester signals measured by 31P magnetic resonance spectroscopy at 3 and 7 Tesla. PLoS ONE. 2021;16:e0248632. doi: 10.1371/journal.pone.0248632. PubMed DOI PMC

Conley K.E., Ali A.S., Flores B., Jubrias S.A., Shankland E.G. Mitochondrial NAD(P)H In vivo: Identifying Natural Indicators of Oxidative Phosphorylation in the (31)P Magnetic Resonance Spectrum. Front. Physiol. 2016;7:45. doi: 10.3389/fphys.2016.00045. PubMed DOI PMC

Meyerspeer M., Boesch C., Cameron D., Dezortová M., Forbes S.C., Heerschap A., Jeneson J.A.L., Kan H.E., Kent J., Layec G., et al. 31P magnetic resonance spectroscopy in skeletal muscle: Experts’ consensus recommendations. NMR Biomed. 2021;34:e4246. doi: 10.1002/nbm.4246. PubMed DOI PMC

Purvis L.A.B., Clarke W.T., Valkovič L., Levick C., Pavlides M., Barnes E., Cobbold J.F., Robson M.D., Rodgers C.T. Phosphodiester content measured in human liver by in vivo (31) P MR spectroscopy at 7 tesla. Magn. Reson. Med. 2017;78:2095–2105. doi: 10.1002/mrm.26635. PubMed DOI PMC

De Graaf R.A., De Feyter H.M., Brown P.B., Nixon T.W., Rothman D.L., Behar K.L. Detection of cerebral NAD(+) in humans at 7T. Magn. Reson. Med. 2017;78:828–835. doi: 10.1002/mrm.26465. PubMed DOI PMC

Peeters T.H., van Uden M.J., Rijpma A., Scheenen T.W.J., Heerschap A. 3D (31) P MR spectroscopic imaging of the human brain at 3 T with a (31) P receive array: An assessment of (1) H decoupling, T(1) relaxation times, (1) H-(31) P nuclear Overhauser effects and NAD(+) NMR Biomed. 2019;34:e4169. doi: 10.1002/nbm.4169. PubMed DOI PMC

Pollock A.S. Intracellular pH of hepatocytes in primary monolayer culture. Am. J. Physiol. 1984;246:F738–F744. doi: 10.1152/ajprenal.1984.246.5.F738. PubMed DOI

Strazzabosco M., Poci C., Spirlì C., Zsembery A., Granato A., Massimino M.L., Crepaldi G. Intracellular pH regulation in Hep G2 cells: Effects of epidermal growth factor, transforming growth factor-alpha, and insulinlike growth factor-II on Na+/H+ exchange activity. Hepatology. 1995;22:588–597. PubMed

Kim J.H., Johannes L., Goud B., Antony C., Lingwood C.A., Daneman R., Grinstein S. Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc. Natl. Acad. Sci. USA. 1998;95:2997–3002. doi: 10.1073/pnas.95.6.2997. PubMed DOI PMC

Nedergaard M., Kraig R.P., Tanabe J., Pulsinelli W.A. Dynamics of interstitial and intracellular pH in evolving brain infarct. Am. J. Physiol. 1991;260:R581–R588. doi: 10.1152/ajpregu.1991.260.3.R581. PubMed DOI PMC

Akhmedov D., Braun M., Mataki C., Park K.S., Pozzan T., Schoonjans K., Rorsman P., Wollheim C.B., Wiederkehr A. Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells. FASEB J. 2010;24:4613–4626. doi: 10.1096/fj.10-162222. PubMed DOI

Santo-Domingo J., Demaurex N. The renaissance of mitochondrial pH. J. Gen. Physiol. 2012;139:415–423. doi: 10.1085/jgp.201110767. PubMed DOI PMC

Labotka R.J., Kleps R.A. A phosphate-analogue probe of red cell pH using phosphorus-31 nuclear magnetic resonance. Biochemistry. 1983;22:6089–6095. doi: 10.1021/bi00295a008. PubMed DOI

Labotka R.J. Measurement of intracellular pH and deoxyhemoglobin concentration in deoxygenated erythrocytes by phosphorus-31 nuclear magnetic resonance. Biochemistry. 1984;23:5549–5555. doi: 10.1021/bi00318a026. PubMed DOI

Kemp G.J., Meyerspeer M., Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: A quantitative review. NMR Biomed. 2007;20:555–565. doi: 10.1002/nbm.1192. PubMed DOI

McDowell R.W., Stewart I. Peak assignments for phosphorus-31 nuclear magnetic resonance spectroscopy in pH range 5-13 and their application in environmental samples. Chem. Ecol. 2005;21:211–226. doi: 10.1080/02757540500211590. DOI

Moon R.B., Richards J.H. Determination of intracellular pH by 31P magnetic resonance. J. Biol. Chem. 1973;248:7276–7278. doi: 10.1016/S0021-9258(19)43389-9. PubMed DOI

Sedivy P., Drobny M., Dezortova M., Herynek V., Roztocil K., Cermakova H., Nemcova A., Dubsky M., Hajek M. 31P-MR spectroscopy in patients with mild and serious lower limb ischemia. Int. Angiol. 2018;37:293–299. doi: 10.23736/S0392-9590.18.03943-3. PubMed DOI

Rata M., Giles S.L., deSouza N.M., Leach M.O., Payne G.S. Comparison of three reference methods for the measurement of intracellular pH using 31P MRS in healthy volunteers and patients with lymphoma. NMR Biomed. 2014;27:158–162. doi: 10.1002/nbm.3047. PubMed DOI PMC

Jung W.I., Widmaier S., Seeger U., Bunse M., Staubert A., Sieverding L., Straubinger K., van Erckelens F., Schick F., Dietze G., et al. Phosphorus J coupling constants of ATP in human myocardium and calf muscle. J. Magn. Reson. B. 1996;110:39–46. doi: 10.1006/jmrb.1996.0005. PubMed DOI

De Graaf R.A. In Vivo NMR Spectroscopy, Principles and Techniques. 2nd ed. John Wiley&Sons Ltd.; Chichester, UK: 2007. pp. 1–570.

Turner B.L., Mahieu N., Condron L.M. Phosphorus-31 nuclear magnetic resonance spectral assignments of phosphorus compounds in soil NaOH-EDTA extracts. Soil Sci. Soc. Am. J. 2003;67:497–510. doi: 10.2136/sssaj2003.4970. DOI

Cade-Menun B.J. Improved peak identification in 31P-NMR spectra of environmental samples with a standardized method and peak library. Geoderma. 2015;257–258:102–114. doi: 10.1016/j.geoderma.2014.12.016. DOI

Cohn M., Hughes T.R., Jr. Nuclear magnetic resonance spectra of adenosine di- and triphosphate. II. Effect of complexing with divalent metal ions. J. Biol. Chem. 1962;237:176–181. doi: 10.1016/S0021-9258(18)81382-5. PubMed DOI

Szabo Z. Multinuclear NMR studies of the interaction of metal ions with adenine-nucleotides. Coord. Chem. Rev. 2008;252:2362–2380. doi: 10.1016/j.ccr.2008.03.002. DOI

Hernández E., Kahl S., Seelig A., Begovatz P., Irmler M., Kupriyanova Y., Nowotny B., Nowotny P., Herder C., Barosa C., et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J. Clin. Investig. 2017;127:695–708. doi: 10.1172/JCI89444. PubMed DOI PMC

Hultman E., Nilsson L.H., Sahlin K. Adenine nucleotide content of human liver. Normal values and fructose-induced depletion. Scand. J. Clin. Lab. Investig. 1975;35:245–251. doi: 10.3109/00365517509095736. PubMed DOI

Traussnigg S., Kienbacher C., Gajdošík M., Valkovič L., Halilbasic E., Stift J., Rechling C., Hofer H., Steindl-Munda P., Ferenci P., et al. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis. Liver Int. 2017;37:1544–1553. doi: 10.1111/liv.13451. PubMed DOI PMC

Cheng M., Bhujwalla Z.M., Glunde K. Targeting Phospholipid Metabolism in Cancer. Front. Oncol. 2016;6:266. doi: 10.3389/fonc.2016.00266. PubMed DOI PMC

Tosner Z., Dezortova M., Tintera J., Hajek M. Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver. Magma. 2001;13:40–46. doi: 10.1007/BF02668649. PubMed DOI

Pfleger L., Halilbasic E., Gajdošík M., Benčíková D., Chmelík M., Scherer T., Trattnig S., Krebs M., Trauner M., Krššák M. Concentration of Gallbladder Phosphatidylcholine in Cholangiopathies: A Phosphorus-31 Magnetic Resonance Spectroscopy Pilot Study. J. Magn. Reson. Imaging. 2021 doi: 10.1002/jmri.27817. PubMed DOI

De Haan J.H., Klomp D.W., Tack C.J., Heerschap A. Optimized detection of changes in glucose-6-phosphate levels in human skeletal muscle by 31P MR spectroscopy. Magn. Reson. Med. 2003;50:1302–1306. doi: 10.1002/mrm.10630. PubMed DOI

Roden M., Krssak M., Stingl H., Gruber S., Hofer A., Furnsinn C., Moser E., Waldhausl W. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999;48:358–364. doi: 10.2337/diabetes.48.2.358. PubMed DOI

Rothman D.L., Shulman R.G., Shulman G.I. P-31 Nuclear-Magnetic-Resonance Measurements of Muscle Glucose-6-Phosphate—Evidence for Reduced Insulin-Dependent Muscle Glucose-Transport or Phosphorylation Activity in Non-Insulin-Dependent Diabetes-Mellitus. J. Clin. Investig. 1992;89:1069. doi: 10.1172/JCI115686. PubMed DOI PMC

Cline G.W., Petersen K.F., Krssak M., Shen J., Hundal R.S., Trajanoski Z., Inzucchi S., Dresner A., Rothman D.L., Shulman G.I. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N. Engl. J. Med. 1999;341:240. doi: 10.1056/NEJM199907223410404. PubMed DOI

Noren B., Dahlqvist O., Lundberg P., Almer S., Kechagias S., Ekstedt M., Franzén L., Wirell S., Smedby O. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur. J. Radiol. 2008;66:313–320. doi: 10.1016/j.ejrad.2007.06.004. PubMed DOI

Buchli R., Meier D., Martin E., Boesiger P. Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part II: Muscle, liver, kidney. Magn. Reson. Med. 1994;32:453–458. doi: 10.1002/mrm.1910320405. PubMed DOI

Li C.W., Negendank W.G., Murphy-Boesch J., Padavic-Shaller K., Brown T.R. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed. 1996;9:141–155. doi: 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P. PubMed DOI

Chmelík M., Schmid A.I., Gruber S., Szendroedi J., Krššák M., Trattnig S., Moser E., Roden M. Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver. Magn. Reson. Med. 2008;60:796–802. doi: 10.1002/mrm.21762. PubMed DOI

Laufs A., Livingstone R., Nowotny B., Nowotny P., Wickrath F., Giani G., Bunke J., Roden M., Hwang J.-H. Quantitative liver 31 P magnetic resonance spectroscopy at 3T on a clinical scanner. Magn. Reson. Med. 2014;71:1670–1675. doi: 10.1002/mrm.24835. PubMed DOI

Pfleger L., Gajdošík M., Wolf P., Smajis S., Fellinger P., Kuehne A., Krumpolec P., Trattnig S., Winhofer Y., Krebs M., et al. Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using (31)P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age. J. Magn. Reson. Imaging. 2019;49:597–607. doi: 10.1002/jmri.26225. PubMed DOI PMC

Hooijmans M.T., Doorenweerd N., Baligand C., Verschuuren J., Ronen I., Niks E.H., Webb A.G., Kan H.E. Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up. PLoS ONE. 2017;12:e0182086. doi: 10.1371/journal.pone.0182086. PubMed DOI PMC

Krumpolec P., Klepochova R., Just I., Tusek Jelenc M., Frollo I., Ukropec J., Ukropcova B., Trattnig S., Krssak M., Valkovic L. Multinuclear MRS at 7T Uncovers Exercise Driven Differences in Skeletal Muscle Energy Metabolism Between Young and Seniors. Front. Physiol. 2020;11:644. doi: 10.3389/fphys.2020.00644. PubMed DOI PMC

Klepochova R., Valkovic L., Hochwartner T., Triska C., Bachl N., Tschan H., Trattnig S., Krebs M., Krssak M. Differences in Muscle Metabolism Between Triathletes and Normally Active Volunteers Investigated Using Multinuclear Magnetic Resonance Spectroscopy at 7T. Front Physiol. 2018;9:300. doi: 10.3389/fphys.2018.00300. PubMed DOI PMC

Roper D., Layton M. Investigation of the hereditary haemolytic anaemias: Membrane and enzyme abnormalities. In: Lewis S., Bain B., Bates I., editors. Dacie and Lewis Practical Haematology. 10th ed. Elsevier; Amsterdam, The Netherlands: 2006. DOI

Lu M., Zhu X.H., Zhang Y., Chen W. Intracellular Redox State Revealed by In Vivo P-31 MRS Measurement of NAD(+) and NADH Contents in Brains. Magn. Reson. Med. 2014;71:1959–1972. doi: 10.1002/mrm.24859. PubMed DOI PMC

Lu M., Zhu X.H., Chen W. In vivo P-31 MRS assessment of intracellular NAD metabolites and NAD(+)/NADH redox state in human brain at 4 T. NMR Biomed. 2016;29:1010–1017. doi: 10.1002/nbm.3559. PubMed DOI PMC

Chouinard V.A., Kim S.Y., Valeri L., Yuksel C., Ryan K.P., Chouinard G., Cohen B.M., Du F., Öngür D. Brain bioenergetics and redox state measured by (31)P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizoph. Res. 2017;187:11–16. doi: 10.1016/j.schres.2017.02.024. PubMed DOI PMC

Henriksson J., Katz A., Sahlin K. Redox state changes in human skeletal muscle after isometric contraction. J. Physiol. 1986;380:441–451. doi: 10.1113/jphysiol.1986.sp016296. PubMed DOI PMC

Sarma R.H., Lee C.H., Hruska F.E., Wood D.J. H-1, H-1-[P-31], P-31, and P-31-[H-1] fast Fourier transform NMR study of solution conformation of cofactors involved in glycogen synthesis: Adenosinediphosphoglucose and uridinediphosphoglucose. FEBS Lett. 1973;36:157–162. doi: 10.1016/0014-5793(73)80359-X. PubMed DOI

Stefan D., Cesare F.D., Andrasescu A., Popa E., Lazariev A., Vescovo E., Strbak O., Williams S., Starcuk Z., Cabanas M., et al. Quantitation of magnetic resonance spectroscopy signals: The jMRUI software package. Meas. Sci. Technol. 2009;20:104035. doi: 10.1088/0957-0233/20/10/104035. DOI

Gajdosik M., Landheer K., Swanberg K.M., Juchem C. INSPECTOR: Free software for magnetic resonance spectroscopy data inspection, processing, simulation and analysis. Sci. Rep. 2021;11:2094. doi: 10.1038/s41598-021-81193-9. PubMed DOI PMC

Deelchand D.K., Ugurbil K., Henry P.G. Investigating brain metabolism at high fields using localized 13C NMR spectroscopy without 1H decoupling. Magn. Res. Med. 2006;55:279–286. doi: 10.1002/mrm.20756. PubMed DOI

Skupienski R., Do K.Q., Xin L. In vivo 31P magnetic resonance spectroscopy study of mouse cerebral NAD content and redox state during neurodevelopment. Sci. Rep. 2020;10:15623. doi: 10.1038/s41598-020-72492-8. PubMed DOI PMC

Hájek M., Palyzová D., Korínek M., Kurková D. Concentrations of free mg2+, pH and 31P MR metabolite ratios in calf muscles of healthy controls and patients with primary juvenile hypertension. Physiol. Res. 2002;51:159–167. PubMed

Henry P.G., Oz G., Provencher S., Gruetter R. Toward dynamic isotopomer analysis in the rat brain in vivo: Automatic quantitation of 13C NMR spectra using LCModel. NMR Biomed. 2003;16:400–412. doi: 10.1002/nbm.840. PubMed DOI